Researchers have developed an AI tool called MindGlide that can analyze MRI scans to assess the efficacy of multiple sclerosis treatments, potentially revolutionizing disease management.
The Center for Health + Technology (CHeT) at the Del Monte Institute for Neuroscience is at the forefront of transforming clinical research and improving health outcomes for individuals with neurological conditions.
